Vall d'Hebron Hospital Completes Europe's First Single-Port Robotic Pediatric Nephroureterectomy Using China's Surgerii SystemCoinLive·Jul 5 at 04:26 PM600521+1.84%02096-0.48%
Chinese Drugmaker Huahai Rises After Signing USD340 Million Deal With Spain’s AlmirallYicai·Mar 30 at 08:02 AM600521+1.84%
The CSI Convertible Bond Index opened down 0.38%. Jiaze Convertible Bonds, Jingda Convertible Bonds, Bester Convertible Bonds, TZTEK Convertible Bonds, and HUAYA INTELLIGENCE Convertible Bonds saw the largest declines, falling 3.04%, 2.99%, 2.97%, 2.74%, and 2.69% respectively. ChangGao NEET Convertible Bonds, Shandong Head Group Convertible Bonds, TRE Convertible Bonds, JINHONG GAS Convertible Bonds, and huahaipharm Convertible Bonds led the gains, rising 30.00%, 10.00%, 3.87%, 3.83%, and 3.56% respectivelyWallstreetcn·Mar 29 at 08:29 PM600521+1.84%688106+5.79%
National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance36Kr·Jan 30 at 08:39 PM002038+2.79%512290+0.70%
Huahaipharm's subsidiary, Ruixiqi's Bevacizumab Injection marketing authorization application has been acceptedZhitong·Oct 9, 2025 at 04:34 AM600521+1.84%
Huahaipharm: Carboxymethyl Sodium Injection has obtained a drug registration certificateZhitong·Sep 22, 2025 at 05:22 AM600521+1.84%
Huahaipharm: Huaotai has received FDA approval to conduct Phase I clinical trials of injectable HB0043 in the United StatesZhitong·Sep 17, 2025 at 05:03 AM600521+1.84%
Huahaipharm: Two products have obtained drug registration certificatesZhitong·Sep 16, 2025 at 04:16 AM600521+1.84%
Innovative drug concept stocks show partial strength, Thalys hits the limit upZhitong·Sep 11, 2025 at 10:09 PM603127+5.94%06127+2.07%
Huahaipharm's subsidiary Huahai Jiancheng passes on-site inspection by the US FDAZhitong·Sep 9, 2025 at 04:48 AM600521+1.84%
The chemical pharmaceutical sector fluctuated and weakened, with Huahai Pharmaceutical hitting the limit downZhitong·Sep 9, 2025 at 01:38 AM600521+1.84%
Huahaipharm hit the daily limit and achieved 2 consecutive trading limits, with a cumulative increase of 21.03% over 2 daysZhitong·Sep 1, 2025 at 12:05 AM600521+1.84%
The concept of innovative drugs has risen again, with Chemexpress up over 15%Zhitong·Aug 29, 2025 at 12:16 AM688131+0.80%603590+1.25%
The chemical pharmaceutical sector fluctuated and weakened, with TIBET AIM PHARM hitting the limit down, followed by Lifeon Pharmaceutical, JLPC, huahaipharm, Foyou Pharma, and CHENGYIPHARMAZhitong·Aug 20, 2025 at 09:08 PM002826+4.26%003020+4.58%
Huahaipharm: Injectable HB0043 has obtained permission for clinical drug trialsZhitong·Jul 31, 2025 at 04:19 AM600521+1.84%
